Search
Menu
Gentec Electro-Optics Inc   - Measure With Gentec Accuracy LB

Fairway Medical Technologies Inc.

Facebook X LinkedIn Email
Fairway Medical Technologies Inc. of Houston has received $3.8 million in federal funding to conduct Phase II research on optoacoustic breast and prostate cancer diagnostic methods. The NIH’s National Cancer Institute has awarded the company $2.7 million to develop its laser-ultrasound-nanotechnology system for animal tests and a $1.1 million Small Business Innovation Research grant for the development of a commercial prostate cancer early-detection system. The laser-based technology is used with gold nanorods bound to antibodies to allow higher contrast and definition. It has the potential to detect tumors as small as 2 mm and can differentiate between benign and malignant tumors.

Seno Medical Instruments of San Antonio has purchased Fairway Medical’s optoacoustic technology and will introduce it as a real-time breast cancer detection and diagnosis method. The company will help fund the system’s initial commercialization steps.
Hamamatsu Corp. - Earth Innovations MR 2/24

Published: December 2006
BiophotonicsBusinessRapidScan

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.